Up

Doctor of Pharmacy (PharmD) Program
Summary, 2009-10 Academic Year

Program Director
Dr. Mary H.H. Ensom

Clinical Coordinator
Dr. Patricia Gerber

I.    Program Objectives
II.   Career Path and Employment Opportunities
III.  Program Description
IV. The Curriculum
    1. Teaching and Learning Philosophy
    2. Course Requirements
    3.  First Year Courses
    4.  First Year Course Descriptions
    5.  Second Year of Program Course Descriptions
        a.  Core Rotations
        b.  Optional/Elective Rotations
        c.  Clinical Rotation Sites
    6.  Student Assessment
V.    Admission Requirements
VI.   The Application Process
VII.  Tuition
VIII. Student Financial Aid
IX.   Faculty
X.    Graduates

The mission of the Faculty of Pharmaceutical Sciences at the University of British Columbia (U.B.C.) is to advance knowledge, health care outcomes, and the profession through leadership and innovation in research, education and scholarly activity in the pharmaceutical sciences.

The Faculty established the first Canadian Doctor of Pharmacy (PharmD) program in 1991.

The program is a 20-month post-baccalaureate professional degree providing advanced education in clinical pharmacy practice. Individuals completing the program will be capable of fulfilling advanced clinical pharmacy roles in hospitals, ambulatory care or community-based sites, universities, industry and in health care agencies.

The program is designed for full-time study. Presently, part-time or "non-traditional" degree options are not available. While pharmacy schools in the United States offer the "entry-level" PharmD degree, the program at U.B.C. will continue to be structured on a post-BSc degree basis.

The post-baccalaureate PharmD program at U.B.C. is fully accredited by the Canadian Council for the Accreditation of Pharmacy Programs.

The general objective of the program is to train pharmacists at an advanced level, providing them with the knowledge and skills to function in a variety of clinical settings to:

1. Recognize from a patient's presentation (signs, symptoms, lab tests and diagnoses) any disease states, symptoms or abnormal laboratory values which may require or indicate a need for drug therapy, be aggravated or induced by drug therapy or alter the selection and/or dosing regimen of drugs.

2. Collect or interpret relevant information from the patient's drug history, medical history, physical exam or progress notes in order to present an assessment of the patient's health problems.

3. Design an appropriate therapeutic regimen or plan, based on patient specific information. This would include establishing appropriate clinical outcomes, designing and monitoring a treatment regimen involving appropriate drug or drugs and associated dosage regimens.

4. Monitor and assess the therapeutic and adverse effects of a given patient's drug therapy through selection and evaluation of physical and laboratory parameters.

5. Utilize knowledge of pharmacokinetics and other patient parameters to design optimal dosage regimens.

6. Critically evaluate and utilize drug literature.

7. Understand the fundamentals of clinical research.

8. Effectively communicate, verbally and in writing with patients, peers and other health professionals.

Significant changes and restructuring are taking place within the Canadian health care system and the pharmacy profession. In some regions of the country, many traditional opportunities for pharmacists, particularly in the institutional setting are closing, while at the same time new career paths are opening. Prospective applicants to the program should have a reasonably informed understanding of how various political, economic and societal forces are influencing the profession and, by inference, career opportunities for pharmacists holding baccalaureate, PharmD or other educational credentials.

The general view holds that the "typical" career focus of most PharmD graduates leans toward clinical practice in large, tertiary care hospitals. The structure of post-BSc PharmD programs, including that offered by U.B.C., are also designed to meet this intent. However, every effort is made to provide our graduates with a strong education in many advanced "generic" skills that are transferable to practice in diverse pharmacy and health care settings or to provide a foundation for further formal education in specialty residencies and fellowships.

In addition to traditional acute care hospital practice, the PharmD program provides excellent training to prepare individuals for innovative pharmacy careers in long-term care, ambulatory care, community pharmacy, consulting, pharmaceutical industry, academia, government, managed care, professional organizations, and research.

There are considerable regional and provincial variations in the extent of opportunities that may exist for PharmD graduates in each of these career fields. The program at the University of British Columbia welcomes applications from individuals outside the province. Since the start of the program in 1991, institutions in the Vancouver area have absorbed many of our graduates. Applicants, however, should not assume that job opportunities in these facilities will always be readily available to graduates.

The PharmD program is comprised of 2 major components - 8 months (2 academic terms) of formal didactic course-work followed by 12 months of experiential training (i.e., clinical clerkships). The didactic curriculum provides the student with a core of professional knowledge and skills in the biomedical, pharmaceutical and clinical sciences. This ensures a strong educational base for the clinical component of the program. The emphasis in the first year is on human pathophysiology and advanced pharmacotherapeutics. The Human Pathology course is taught by members of the Faculty of Medicine. Other courses include Advanced Concepts in Pharmacokinetics, Physical Assessment, Critical Appraisal of Pharmacotherapy Literature, Advanced Clinical Pharmacokinetics, Advanced Pharmacy Administration, Immunopathology, Clinical Skills Development and the PharmD Seminar series.

The experiential training component provides the student with the opportunity to apply knowledge acquired in the didactic program, as well as provide new learning experiences in a variety of patient care settings. In addition to developing and refining advanced pharmacy practice skills, students gain confidence and judgment. Most clerkships are under the preceptorship of a practicing pharmacotherapeutics specialist, typically on a one-on-one basis.

Core rotations in adult general medicine, critical care, cardiology, pediatrics, ambulatory care or community-based practice, internal and emergency medicine are required of all students. The remaining clerkships are selected by the student (based upon availability) from a wide range of options, including infectious diseases, pediatrics, other specialties or clinical research. The optional and elective clerkships provide an opportunity for expanding knowledge of drug therapy in specialty areas of clinical and pharmacy practice.

Students who wish to gain experience in clinical research may do so through the completion of an elective rotation. Student participation in minor projects and publication is available in several of the clinical rotations.

The PharmD program at U.B.C. strives to provide an environment for learning that will contribute to the education of individuals who will become pharmacy practice leaders in the profession and the Canadian health care system. The Faculty of Pharmaceutical Sciences believes that this can be achieved through a curriculum that offers a strong foundation in pharmacotherapeutics, disease processes, pharmacokinetics and clinical evaluation methods supplemented by practice experiences in high quality clinical teaching settings working with role model pharmacy practitioners. In collaboration with other healthcare team members, PharmD students will be expected to develop strong skills in the identification and resolution of patient-specific drug-related problems using pharmaceutical care methods.

The PharmD program does not rely solely on one dominant instructional method. Students will be placed in a variety of teaching experiences including large classroom didactic settings, small group lectures, small group discussions, case study learning, problem-based learning, tutorials, seminars, practice simulations, and electronic media settings. Each instructional method is intended to provide the most effective approach to the development of defined practice competencies in the student. In addition, the program expects that all students will have a reasonable level of confidence to study in an environment that encourages independent and self-directed learning.

The PharmD program assumes that all students will have good personal computer and common software application skills. Extensive use of this technology by students for e-mail communication, word processing, data analysis, presentation preparation and database searches can be anticipated. To assist students in this area, the PharmD Student Office is equipped with a personal computer, wireless network and printer. All students are provided access to email, newsgroups and the Internet. A personal computer (desktop or portable) is a requirement for all students. A laptop computer is beneficial for Seminars and presentations while on rotation.

The PharmD program requires 20 months of continuous study. The first year didactic portion begins in late August and continues through to the following April. The second year experiential training (i.e., clinical clerkships) begins in late April and continue for twelve months until completion of the program in late April of the following year.

3.  First Year Courses

Pharmacotherapeutic management of selected acute and chronic diseases and disorders. Emphasis is on designing and monitoring of drug therapy to ensure optimal therapeutic outcomes.

Advanced Concepts in Pharmacokinetics

Models of linear and dose-dependent systems in pharmacokinetics.

This course is designed to provide students with the skills required by clinical pharmacy specialists to identify, evaluate, and apply evidence relevant to improving pharmacy practice and patient care. The goal of this course is to provide students with an understanding of the principles and applications of biostatistics within an environment specific to clinical pharmacy.

Pharmacokinetic applications in therapeutic drug monitoring and patient care; specific drugs and disease states, effects of age and concomitant drug administration.

This 2-part course is intended to provide a forum for students to prepare and orally present current therapeutic and research material and discuss issues pertinent to clinical pharmacy practice. Critical literature evaluation skills are taught.

Institutional, professional and regulatory factors influencing the planning, implementation and control of pharmacy services in hospitals.

Principles of and clinical experience in physical assessment of patients for monitoring of drug efficacy and toxicity, interpretation of objective patient data by the clinical pharmacist.

Immunological events causing tissue injury. Topics covered include antigenicity and immunization, physiology of the immune response, immune injury, immunodeficiency diseases and autoimmunity.

This course covers the basic principles of general pathology and their application on a systemic basis. Emphasis is placed on the etiology, pathogenesis and natural history of diseases amenable to drug therapy. Disordered physiology and biochemistry are correlated with the pathologic lesions that comprise organic disease.

5.  Second Year of Program Course Descriptions

Experiential Training Component (Rotations)

a. Required Rotation for 2009-10

Cardiology
Community-Based Practice
Critical Care
Emergency Medicine
Internal Medicine
Infectious Diseases
Pediatrics
Psychiatry

The following is a list of potential optional and elective rotations, subject to preceptor availability and scheduling:

Clinical Research
Consulting
Drug Information
Drug Use Evaluation
Geriatrics
Hepatology
HIV
Infectious Diseases Research
Leukemia and Stem Cell Transplantation
Nephrology
Neurology
Oncology
Outcomes Research
Pediatrics Critical Care
PharmaCare
Pharmaceutical Industry
Pharmacoeconomics
Physical Examination
Psychiatry
Solid Organ Transplantation
Toxicology

...and many others 

Vancouver and the B.C. Lower Mainland area provide PharmD students with a number of excellent health care institutions and ambulatory or community-based practice sites in which to gain clinical experience. These include:

B.C. Cancer Agency (BCCA)

B.C. Centre for Disease Control (BCCDC)

B.C. Drug and Poison Information Centre (DPIC)

Children's and Women's Health Centre of B.C.

Fraser Health Authority (including Burnaby Hospital, Burnaby Regional Cancer Centre, Burnaby Mental Health, Langley Hospital, MSA Hospital, Peace Arch Hospital, Royal Columbian Hospital, Surrey Memorial Hospital)

Vancouver Coastal Health- Providence Health Care (including Lions Gate Hospital, St. Paul's Hospital [SPH], Vancouver General Hospital)

Mid-Main Community Health Centre

Riverview Hospital

UBC Family Practice Unit (FPU)

In addition, the program has an excellent network of contacts at numerous clinical and teaching sites across Canada and the United States. In circumstances where unique clinical learning experiences are needed and are not available in any of our usual affiliated teaching sites in the Vancouver area, special arrangements are considered.

6. Student Assessment

During the first year of the program, the academic performance of each student is continually assessed through a variety of formative and summative methods. Examinations, written papers, projects, oral presentations and skill performance demonstrations are used to assess student progress and contribute to the final grade assigned for each course in the first year of the program. A final percent grade is required for most courses and the policy for pass standing for all courses, promotion to the second year, and graduation is set by the Faculty of Graduate Studies.

During the second year of training, students are also assessed in each clinical rotation. Satisfactory performance in all of the core and optional/elective clinical rotations is required to be eligible for graduation. Second year students are also assessed via a series of comprehensive examinations. These exams provide a measure of the student’s ability to problem solve standardized cases in a supervised setting. Satisfactory completion of these comprehensive assessments is required for graduation.

Class size is limited. All applicants must:

1. Hold a Bachelors degree in pharmacy AND;
2. Hold current registration as a pharmacist in British Columbia OR;
3. Hold registration (Qualifying Examination) with the Pharmacy Examining Board of Canada AND be eligible for registration as an out-of-province graduate with the College of Pharmacists of British Columbia. Students with questions regarding this eligibility are encouraged to contact the College.

Other selection criteria include:

1. At least an 80% grade in at least twelve credits of the course work and at least 74% grade in the remaining course work in the last two years of the Bachelor of Science in Pharmacy. Applicants who do not meet this requirement, but have sufficient formal training and relevant professional experience to offset the deficiency may be granted admission.
2. A post-BSc residency diploma in hospital or community pharmacy practice is desired, but not mandatory.
3. Letters of reference.
4. A written personal statement of no more than 250 words indicating professional and career goals.
5. A personal interview with selection committee (only after the initial screening and ranking of applications have been completed).
6. Admission is based on the above criteria, interviews and reference letters.

Applications are to be made on line. The deadline for application is January 15 for the upcoming academic year.  Check for information regarding this process on the PharmD Home page and/or the PharmD Application web page.

Tuition fees at UBC remain the lowest in the country. Tuition fees for the graduating class of 2011 (August 2009 program start date), as determined by the University policy for market-related tuition for professional graduate programs, will be approximately $41,500 for the 20-month program. Tuition fees for international students will be approximately this amount. Final fees are announced by the University in the February/March preceding the start of the academic year in September. Miscellaneous student fees are approximately $200 per year. For more information, please visit the Frequently Asked Questions section of this website.

For information, please visit the Frequently Asked Questions section of this website.

Mary H. H. Ensom, BSc (Pharm) (Kentucky), PharmD (Kentucky), Professor and Director, PharmD Program, Distinguished University Scholar, and Clinical Pharmacy Specialist, Children's and Women's Health Centre of British Columbia.

Bruce C. Carleton, BPharm (Wash State), PharmD (Utah), Associate Professor and Director, Pharmaceutical Outcomes Research Programme, Children's and Women's Health Centre of British Columbia.

Dawn Dalen, BSc(Pharm) (Sask), PharmD (Brit. Col.), Regional Pharmacy Practice Coordinator, Interior Health Authority, Clinical Instructor and Debate Coordinator (Pharmacy 554).

Patricia Gerber, BSc (Pharm) (Brit. Col.), PharmD (Brit. Col.), FCSHP. Assistant Professor (Part Time), Clinical Coordinator, Doctor of Pharmacy Program.

Marc Levine, BSc (McG.), BSc (Pharm) (Brit. Col.), Ph.D. (McM.), Professor.

Peter Loewen, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Associate Professor (Part Time) (UBC), Regional Pharmacy Coordinator, Education & Research, Vancouver Coastal Health/Providence Health Care, and Pharmacotherapeutic Specialist (Medicine), UBC Hospital.

Sam Louie, B.Sc. (Pharm.) (Brit. Col.), Manager, Pharmacy Dept, Lions Gate Hospital, NSCG, Vancouver Coastal Health and Adjunct Professor/ Course Coordinator (Pharmacy 554).

Carlo Marra, BSc (Pharm), PharmD, Ph.D. (Brit. Col.), Assistant Professor and Member, Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute.

Fawziah Marra, BSc (Pharm), PharmD (Brit. Col.), Associate Professor and Director, Pharmacy and Vaccine Services BC Centre for Disease Control.

James P. McCormack, BSc, BSc (Pharm.) (Brit. Col.), PharmD (Medical Univ South Carolina), Professor

Penelope F. Miller, BSc (Pharm) (Brit. Col.), M.A. (San Diego State), Senior Instructor.

Wayne Riggs, BSc (Pharm), M.Sc, Ph.D. (Brit. Col.), Professor, Division of Pharmaceutics and Biopharmaceutics.

Adil Virani, BSc (Pharm) (Brit. Col.), PharmD (Brit. Col.), Assistant Professor (Part Time), Manager, Pharmacy Services (Interim) and Community, Residential and Health Promotion, Fraser Health Authority.

Clinical Faculty

Shirin Abadi, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Toronto), Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency (Vancouver Centre); Clinical Assistant Professor, UBC.

Margaret Ackman, B.Sc. (Pharm.) (Brit. Col.), UBC. (Brit. Col.), Clinical Practice Leader, Regional Pharmacy Services, Capital Health Authority; Clinical Instructor, UBC.

Tejinder Bains, B.Sc. (Pharm.) (Brit. Col.), Pediatric Oncology Pharmacist, Pharmacy Department, Children�fs Hospital of Eastern Ontario; Clinical Instructor, UBC.

Robert Balen, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Informatics Coordinator, CSU Pharmaceutical Sciences, Royal Columbian Hospital; Clinical Associate Professor, UBC.

Teresa Betts, B.Sc. (Pharm.) (Brit. Col.), Clinical Coordinator, Pharmacy Practice, Lions Gate Hospital; Clinical Instructor, UBC.

Glen Brown, B.Sc. (Pharm.) (Manitoba), Pharm.D. (Massachusetts.), Chief Paramedical, Department of Pharmacy, St. Paul�fs Hospital; Clinical Professor, UBC.

Barbara Cadario, B.Sc. (Pharm.) (Toronto), M.Sc. (Brit. Col.), Coordinator, BC Regional Adverse Drug Reaction Centre, BC Drug & Poison Information Centre; Clinical Assistant Professor, UBC.

Lily Cheng, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Clinical Practice Leader, Fraser Health Authority, Burnaby Hospital; Clinical Assistant Professor, UBC.

Elaine Chong, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Director of Evaluation, Drug Use Optimization, Pharmaceutical Sciences Division, Ministry of Health Services; Clinical Assistant Professor, UBC.

Frances Chow, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Washington), Clinical Pharmacy Specialist - NICU, General Pediatrics, Obstetrics, Royal Columbian Hospital; Clinical Assistant Professor, UBC.

Doson Chua, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Washington), Clinical Pharmacotherapeutic Specialist, Cardiology, Providence Health Care, St. Paul�fs Hospital; Clinical Assistant Professor, UBC.

Sue Corrigan, B.Sc. (Pharm.) (Alberta), Pharm.D. (Brit. Col.), Clinical Practice Leader, Fraser Health Authority, Surrey Memorial Hospital; Clinical Assistant Professor, UBC.

Dawn Dalen, B.S.P. (Saskatchewan), Pharm.D. (Brit. Col.), Regional Pharmacy Practice Coordinator, Interior Health Authority; Clinical Assistant Professor, UBC.

Jane de Lemos, B.Sc. (Pharm) (London, UK), Pharm.D. (Brit. Col.), MSc. (London, UK), Regional Pharmacy Coordinator, Professional Practice, Regional Pharmacy, Willow Chest Centre, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Professor, UBC.

Mario de Lemos, B.Sc. (Pharm.) (UK), M.Sc. (Clinical Pharmacy) (UK), Pharm.D. (Brit. Col.), Provincial Drug Information Coordinator, Provincial Systemic Therapy Program, BC Cancer Agency (Vancouver Centre); Clinical Assistant Professor, UBC.

Edward Dillon, B.Sc. (Physiology) (Ontario), B.A. (Psychology) (Nova Scotia), B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (New York, USA), Student Education & Residency Coordinator - Fraser Health Authority, Department of Pharmacy, Royal Columbian Hospital; Clinical Professor, UBC.

Priti Flanagan, B.Sc. (Pharm.) (Sask.), Pharm.D. (Brit. Col.), Clinical Pharmacy Practice Leader, Victoria Heights Specialized Geriatric Clinic, Maple Hill Extended Care - A Wing, Fraser Health Authority; Clinical Assistant Professor, UBC.

Sean Gorman, B.Sc. (Pharm.) (Nova Scotia), Pharm.D. (Brit. Col.), Pharmacotherapeutic Specialist, Critical Care, CSU Pharmaceutical Sciences, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Associate Professor, UBC.

Erica Greanya, B.Sc. (Pharm.) (Alberta), Pharm.D. (Brit. Col.), Clinical Pharmacotherapeutic Specialist, Solid Organ Transplantation, , Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Instructor, UBC.

Donald Hamilton, B.Sc. (Biochem.) (Brit. Col.), B.Sc. (Pharm.) (Brit. Col.), Clinical Coordinator, Pharmacy Department, BC Children�fs and Women�fs Health Centre; Clinical Professor, UBC.

Elaine Kam, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Clinical Pharmacy Specialist, Geriatrics, Pharmacy Department, Peace Arch District Hospital; Clinical Instructor, UBC.

Zahra Kanji, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Pharmacotherapeutic Specialist, Critical Care, Lions Gate Hospital; Clinical Associate Professor, UBC.

Debra Kent, BA (Biol.) (California), Pharm.D. (California), Program Supervisor, Poison Control, BC Drug & Poison Information Centre; Clinical Professor, UBC.

Anisha Lakhani, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Washington, USA), Clinical Pharmacy Specialist, Drug Use Evaluation Coordinator, Fraser Health Authority, Fraser Health Authority; Clinical Assistant Professor, UBC.

Tim Lau, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Pharmacotherapeutic Specialist (Infectious Diseases), CSU Pharmaceutical Sciences, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Associate Professor, UBC.

Katherine Lepik, B.Sc. (Pharm.) (Brit. Col.), MSc, Research Coordinator, Pharmacovigilance Program BC Centre for Excellence in HIV/AIDS, BC Centre for Excellence in HIV/AIDS, St. Paul�fs Hospital; Clinical Instructor, UBC.

Shallen Letwin, B.Sc. (Pharm. (Alberta), Pharm.D. (Brit. Col.), Regional Director, Pharmacy Services, Fraser Health, Fraser Health Authority; Clinical Associate Professor, UBC.

Gabriel Loh, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Pharmacotherapeutic Specialist, Critical Care, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Instructor, UBC.

Alan Low, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Chief Operating Officer, Network Healthcare; Clinical Associate Professor, UBC.

Elaine Lum, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Clinical Pharmacy Specialist in Cardiology, Pharmaceutical Sciences Clinical Services Unit, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Assistant Professor, UBC.

Vincent Mabasa, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Site Manager, Pharmacy Services, Burnaby Hospital; Clinical Assistant Professor, UBC.

Alison Macdonald, B.Sc. (Pharm.) (Brit. Col.), Clinical Pharmacist, Department of Pharmacy, Children�fs & Women�fs Health Centre; Clinical Instructor, UBC.

John Macready, B.Sc. (Pharm.) (Toronto), Pharm.D. (Brit. Col.), Clinical Pharmacist, Critical Care, Pediatrics, BC Children�fs and Women�fs Health Centre; Clinical Instructor, UBC.

Rhonda Malyuk, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Minnesota, USA), Alzheimer's Study Education Working Group ADTI project, Geriatric Psychiatry, BC Ministry of Health Services; Clinical Assistant Professor, UBC.

Tania Mysak, B.Sc. (Pharm.) (Sask.), Pharm.D. (Brit. Col.), Clinical Practice Manager, Alberta Health Services, Neuroscience Unit, University of Alberta Hospital; Clinical Assistant Professor, UBC.

Lynne Nakashima, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (N. Carolina), Pharmacy Professional Practice Leader, Department of Pharmacy, BC Cancer Agency (Vancouver Centre); Clinical Professor, UBC.

Anne Nguyen, B.Sc. (Pharm.) (Toronto), Pharm.D. (Brit. Col.), Director Evaluation, Drug Use Optimization, Pharmaceutical Services Division, BC Ministry of Heal Services; Clinical Associate Professor, UBC.

Nilufar Partovi, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (S. Carolina), Operations Director (Acting), Pharmaceutical Sciences (CSU), Vancouver Coastal Health; Clinical Professor, UBC.

Karen Shalansky, B.Sc. (Pharm.) (Toronto), Pharm.D. (S. Carolina), Pharmacotherapeutic Specialist, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Professor, UBC.

Stephen Shalansky, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (South Carolina), Clinical Coordinator, Pharmacy Department, St. Paul�fs Hospital; Clinical Professor, UBC.

Richard Slavik, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Michigan), Regional Manager, Pharmacy Professional Practice, Interior Health Authority; Clinical Associate Professor, UBC.

Victoria Slavik, B.Sc. (Pharm.) (Brit. Col.), UBC. (Brit. Col.), Clinical Pharmacy Specialist - Cardiology, Regional Pharmacy Practice Coordinator, Interior Health Authority; Clinical Assistant Professor, UBC.

Denise Sprague, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Clinical Pharmacy Specialist, Infectious Diseases, Hospital Pharmacy Services, Kelowna General Hospital; Clinical Instructor, UBC.

Anthony Taddei, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Washington, USA), Clinical Pharmacy Specialist, Department of Pharmacy, Royal Columbian Hospital; Clinical Assistant Professor, UBC.

Suzanne Taylor, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Executive Director, Drug Use Optimization, Pharmaceutical Sciences, BC Ministry of Health Services; Clinical Associate Professor, UBC.

Susan Troesch, B.Sc. (Pharm.) (Brit. Col.), Clinical Pharmacist Services, Mid-Main Community Health Centre, Vancouver Coastal Health Authority, Vancouver Coastal Health; Clinical Instructor, UBC.

Thanh Vu, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Coordinator, Canada Vigilance Regional Office - BC and Yukon, Health Products and Food Branch, Health Canada; Clinical Assistant Professor, UBC.

Dawn Warkentin, B.Sc. (Pharm.) (Alberta), Pharm.D. (S. Carolina), Pharmacotherapeutic Specialist, Bone Marrow Transplantation/Hematology, CSU Pharmaceutical Sciences, Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Associate Professor, UBC.

Janet Webb, B.Sc. (Pharm.) (Brit. Col.), M.Sc. (Medicine) (New Foundland), Program Supervisor, BC Drug & Poison Information Centre; Clinical Assistant Professor, UBC.

Janice Yeung, B.Sc. (Pharm.) (Brit. Col.), Pharm.D. (Brit. Col.), Pharmacotherapeutic Specialist - BMT/Leukemia, Pharmaceutical Sciences (CSU), Vancouver Hospital & Health Sciences Centre (VGH Site); Clinical Assistant Professor, UBC.

Eric Yoshida, B.Sc. (Pharm.) (Ontario), MD (Toronto), MHSc (Brit. Col.), Associate Professor, Faculty of Medicine, University of British Columbia; Clinical Assistant Professor, UBC.

Sylvia Zerjav, B.Sc. (Pharm.) (Nova Scotia), Pharm.D. (S. Carolina), Psychopharmacology Consultant, Provincial Health Services Authority, British Columbia; Clinical Professor, UBC.

X.  Graduates

2009

Dr. Jennifer Bolt, Dr. Alice Chan, Dr. Claire Fowkes, Dr. Jennifer Haymond, Dr. Fong Huynh, Dr. Jennifer Isenor, Dr. I Fan Kuo

2008

Dr. Penny Bring, Dr. Rochelle Gellatly, Dr. Faegheh (Fay) Hosseini, Dr. Harjinder Parwana, Dr. Ramandeep (Rumi) Pattar, Dr. Denise Sprague, Dr. Matthew Wiens, Dr. Dalyce Zuk

2007

Dr. Karine Cloutier, Dr. Karen Dahri, Dr. Deonne Dersch, Dr. Kelly Grindrod, Dr. Curtis Harder, Dr. Stefanie Lam, Dr. Gabriel Loh, Dr. Sean Spina, Dr. Ruth Tsang

2006

Dr. Dario Alberton, Dr. Anne Dar Santos, Dr. Tamar Koleba, Dr. Vivian Leung, Dr. Vincent Mabasa, Dr. Judith Marin

2005

Dr. Susan Buchkowsky, Dr. Dawn Dalen, Dr. Erica Greanya, Dr. Sheri Koshman, Dr. Michael Legal, Dr. Elaine Lum, Dr. Mark Makowsky, Dr. Eric Villeneuve

2004

Dr. Sue Corrigan, Dr. Jamie Falk, Dr. Co Pham, Dr. Julie Scott, Dr. Sunita Stenton, Dr. Thanh Vu

2003

Dr. Saira Alladina Ebrahim, Dr. Dave Cecillon, Dr. Elaine Chong, Dr. Victoria Cox, Dr. Christine Davis, Dr. Karen Tulloch

2002

Dr. Roxane Carr, Dr. Deon Druteika, Dr. Andrea Murphy, Dr. Edith St. Pierre, Dr. Jodene Wong, Dr. Janice Yeung

2001

Dr. Lily Cheng, Dr. Sean Gorman, Dr. Leela John, Dr. Timmy Lau, Dr. Payal Patel, Dr. Colette Raymond (Director: Dr. Peter Jewesson)

2000

Dr. Sandy Dubyk, Dr. Eric Lun, Dr. Tania Mysak, Dr. Shannon Sinclair, Dr. Kerry Wilbur. (Director: Dr. Peter Jewesson)

1999

Dr. Robert Balen, Dr. Mario De Lemos, Dr. Anne Nguyen, Dr. Kari Olson, Dr. Sophie Robert, Dr. Priti Thomas. (Director: Dr. Peter Jewesson)

1998 

Dr. Marie-France Beauchesne, Dr. Dana Leigh Cole, Dr. Zahra Esmail (Kanji), Dr. Bruce Lange, Dr. Agnes Lo, Dr. Peter Zed. (Director: Dr. Peter Jewesson)

1997 

Dr. Ema Ferreira, Dr. David Gardner, Dr. Patricia Gerber, Dr. Wendy Gordon, Dr. Christine Hughes, Dr. Adil Virani (Director: Dr. Peter Jewesson) 

1993-1996 

Dr. Donna Buna, Dr. Renette Bartholet, Dr. John Forster-Coull, Dr. Jane Gillis, Dr. Mary Ann Lindsay, Dr. John MacReady, Dr. Leslie Phillips, Dr. Ric Procyshyn, Dr. Linda Sulz, Dr. Jane DeLemos, Dr. Brenda Osmond, Dr. Margaret Ackman, Dr. Rubina Sunderji, Dr. Terryn Naumann, Dr. Fawziah Marra, Dr. Carlo Marra, Dr. Peter Loewen, Dr. Cathy MacDougall, Dr. Suzanne Malfair, Dr. Robin O'Brien, Dr. Alan Low, Dr. Wendy Leong, Dr. Elaine Kam, Dr. Shallen Letwin (Director: Dr. Glenda Meneilly, Dr. David Hill)